LRG-1, a molecule with potential as a diagnostic tool for PAA in pediatric populations, has shown promising results in previous evaluations [13,14,16,18,19,20,21,22,23,24]. The gene discussed is LRG1; the disease is pulmonary artery-aorta diameter ratio measurement.